THETFORD MINES, QUEBEC–(Marketwired – Oct. 20, 2016) – AlliancePharma Inc. (TSX VENTURE:APA) (“AlliancePharma” or the “Corporation“) is pleased to announce that it has issued an aggregate of 40 000 Series A Preferred Shares to Persistence Capital Partners in connection with the $4,000,000 private placement previously announced on July 4, 2016 (the “Private Placement“).